MONOCLONAL ANTIBODY

Clinical trials for MONOCLONAL ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new MONOCLONAL ANTIBODY trials appear

Sign up with your email to follow new studies for MONOCLONAL ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

Breakthrough trial aims to extend lives in aggressive stomach cancers

Disease control Recruiting now

This large Phase 3 study is testing whether adding a new antibody drug called HLX22 to standard treatment helps people with advanced HER2-positive stomach or gastroesophageal cancer live longer without their cancer getting worse. About 550 adults with previously untreated, advanc…

Matched conditions: MONOCLONAL ANTIBODY

Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

MONOCLONAL ANTIBODY

Get alerted when new MONOCLONAL ANTIBODY trials appear

Breakthrough trial aims to extend lives in aggressive stomach cancers